查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
北美孕產婦心理健康市場規模、佔有率和趨勢分析報告：按適應症、治療方法、地區和細分趨勢：2023-2030
市場調查報告書
商品編碼
1321390

北美孕產婦心理健康市場規模、佔有率和趨勢分析報告：按適應症、治療方法、地區和細分趨勢：2023-2030

North America Maternal Mental Health Market Size, Share & Trends Analysis Report By Disease Indication (Postpartum Depression, Dysthymia), By Therapy (Interpersonal Psychotherapy, Antidepressants), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

北美孕產婦心理健康市場的成長和趨勢

Grand View Research, Inc.最新報告顯示，到2030年，北美孕產婦心理健康市場規模預計將達到206.3億美元，2023年至2030年年複合成長率為29.68%。

近年來，由於努力提高認知、改進篩查和評估以及增加獲得護理的機會，美國孕產婦心理健康行業持續成長。然而，差距依然存在，不僅在獲取機會方面，而且在對弱勢群體的心理健康支持方面也存在差距。加拿大政府已實施法規並提供資金來解決孕產婦心理健康問題。

這包括透過就業保險計劃提供產假福利、心理健康戰略、為圍產期心理健康服務提供資金、協作護理模式、研究和資料收集以及對社區組織的支持等舉措。這些舉措目的是改善加拿大各地孕婦和新媽媽獲得心理健康服務和支持的機會。此外，威斯康星州衛生服務部 (DHS) 於2022年 10月宣布，將提供總計 1600 萬美元用於促進孕產婦和兒童健康。這筆資金將透過與威斯康星醫學院推進健康威斯康星捐贈基金和威斯康星大學醫學與公共衛生學院合作，用於減少孕產婦和兒童健康結果的差異。

此外，該計劃還將向國土安全部婦幼健康計劃提供資金，以管理贈款計劃。該計劃資助促進孕產婦和兒童健康公平的努力，以降低孕產婦和嬰兒死亡率並改善威斯康星州家庭的生活狀況。每個合作夥伴將獲得550萬美元的計畫支持。增加的資金將使政府能夠查明每名孕產婦死亡的確切原因。然後，政府將能夠在醫院和其他分娩設施中擴大和實施以接待為基礎的計劃，以解決導致孕產婦健康狀況不佳的根本問題。

15%的新媽媽罹患產後抑鬱症，但往往被汙名、社會期望和缺乏醫學知識所掩蓋。儘管存在與精神疾病相關的汙名，但女性利用文化接受運動來重構她們的產後抑鬱症經歷，挑戰傳統的母性觀念，並成功獲得對其痛苦的認可，表現出獨創性和韌性。在美國，產後抑鬱症的社會汙名是嚴重的問題。因此，一些女性不願意尋求產後抑鬱症治療，因為她們擔心受到污名化或批評。

北美孕產婦心理健康市場報告亮點

  • 2022年，妊娠及產後廣泛性焦慮領域將佔比最大。對包括焦慮症在內的圍產期精神狀態問題的認知和認知的提高是推動該細分市場成長的主要要素。
  • 由於有利的償付方案、篩查意識的提高以及新療法的批准，預計 PPD 領域從2023年到2030年將實現良好的年複合成長率。
  • 2022年，IPT佔據市場主導地位，因為它被認為是治療各種精神疾病的有效療法。
  • 由於政府資金雄厚、研究力度加大以及領先公司的存在等要素，美國在該地區佔據市場領先地位。

目錄

第1章 調查方法和範圍

  • 市場區隔
  • 目的
  • 調查方法
  • 資訊採購
    • 購買資料庫
    • GVR內部資料庫
    • 次要資訊
    • 初步調查
  • 資訊或資料分析
    • 資料分析模型
  • 市場形成和檢驗
  • 型號詳情
    • 產品流向分析
  • 二手資訊清單
  • 簡稱列表
  • 主要資訊清單

第2章 執行摘要

第3章 北美孕產婦心理健康市場變量和趨勢

  • 市場體系預測
    • 母市場預測
  • 市場動態
    • 市場促進因素影響分析
    • 市場限制的影響分析
  • COVID-19 大流行的影響
  • 行業分析工具
    • 波特的分析
    • SWOT 分析：要素因素（政治/法律、經濟/技術）

第4章 北美孕產婦心理健康市場：按適應症分類的估算及趨勢分析

  • 2022年和2030年按適應症分類的波動分析和市場佔有率
  • 按疾病分類
  • 產後抑鬱症
  • 調變
  • 常見的懷孕和產後焦慮
  • 懷孕和產後強迫症
  • 與出生有關的創傷後壓力症候群
  • 其他

第5章 北美孕產婦心理健康市場：按治療方法的估計和趨勢分析

  • 2022年和2030年各療法的變異分析和市場佔有率
  • 按治療
  • 抗抑鬱藥
    • 2018年至2030年全球抗抑鬱藥市場估計和預測
    • 選擇性血清素再回收抑制劑（SSRI）
    • 三環類抗抑鬱藥（TCA）
    • 其他
  • 人際心理治療（IPT）
  • 認知行為療法（CBT）
  • 其他

第6章 北美孕產婦心理健康市場：區域估計和趨勢分析

  • 北美孕產婦心理健康市場：區域預測
  • 北美
    • 2018年至2030年北美孕產婦心理健康市場估計和預測
    • 美國
    • 加拿大

第7章 北美孕產婦心理健康市場：競爭形勢

  • 參與企業
    • Therapy Mama
    • Canopie
    • Pfizer Inc
    • Viatris Inc.
    • GlaxoSmithKline Inc.
    • Alembic Pharmaceuticals Limited
    • Mallinckrodt Inc.
    • Sage Therapeutics, Inc.
    • Bausch Health Companies Inc.
    • Magellan Health, Inc.
  • 參與企業概況
  • 財務績效
  • 產品對標
  • 2022年公司市場佔有率分析
  • 戰略規劃
    • 擴張
    • 獲得
    • 產品/服務發布
    • 其他

第8章 分析師的觀點

Product Code: GVR-4-68040-097-8

North America Maternal Mental Health Market Growth & Trends

The North America maternal mental health market size is expected to reach USD 20.63 billion by 2030, growing at a CAGR of 29.68% from 2023 to 2030, according to a new report by Grand View Research, Inc. The maternal mental health industry in the U.S. has been growing in recent years, with increased awareness, improved screening and assessment, and efforts to enhance access to care. However, disparities in access as well as gaps in mental well-being support for vulnerable populations still exist. The Canadian government has implemented regulations and provided funding to address maternal mental conditions.

These include initiatives such as maternity leave benefits under the Employment Insurance program, mental well-being strategies, funding for perinatal mental health services, collaborative care models, research and data collection, and support for community-based organizations. These efforts aim to improve access to mental well-being services and support for pregnant women and new mothers across Canada. Moreover, the Wisconsin Department of Health Services (DHS) announced awards totaling USD 16 million in October 2022 to enhance maternal and child health. The funds will be invested to close maternal and child health outcomes gaps through collaborations with the Medical College of Wisconsin's Advancing a Healthier Wisconsin Endowment and the University of Wisconsin School of Medicine and Public Health.

In addition, this initiative offers funding to DHS Maternal and Child Health Program to manage a grant program. This program will provide funding for initiatives that promote maternal and child health equity to reduce maternal and infant mortality at the systemic and community levels and improve outcomes for families throughout Wisconsin. Each partner will receive USD 5.5 million to help them with their projects. With the help of increased funds, the government can determine the precise causes of each maternal mortality. The government will then be able to extend and implement evidence-based programs in hospitals and other birthing facilities to deal with the fundamental problems that result in poor maternal condition outcomes.

Although postnatal depression affects 15% of new mothers, it is frequently masked by stigma, societal expectations, and lack of medical knowledge. Despite the stigmatizing nature of mental illness, women have shown ingenuity and resilience by using acceptable cultural movements to reframe their experiences of PPD, challenging conventional views of motherhood, and successfully gaining recognition of their sufferings. The social stigma associated with PPD is a serious problem in the U.S. Many people think PPD is an unreal ailment or a sign of weakness. Therefore, some women might hesitate to seek treatment for PPD out of concern that they would be stigmatized or condemned.

North America Maternal Mental Health Market Report Highlights

  • The pregnancy and postpartum general anxiety segment accounted for the largest share in 2022. Increasing awareness and recognition of perinatal mental condition issues including anxiety disorders is the major factor driving the segment growth
  • The PPD segment is expected to witness a lucrative CAGR through 2023 - 2030 owing to the favorable reimbursement scenario, increasing awareness for screening, and approval of novel therapies
  • IPT dominated the market in 2022 as IPT is considered an effective therapy for treating a variety of mental conditions
  • The U.S. led the regional market due to factors contributing such as robust government funding, increasing research, and the presence of prominent players

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Market Definitions
  • 1.2. Objectives
    • 1.2.1. Objective - 1
    • 1.2.2. Objective - 2
    • 1.2.3. Objective - 3
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. Gvr's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Disease Indication and Therapy Snapshot 1
  • 2.3. Competitive Landscape Snapshot

Chapter 3. North America Maternal Mental Health Market Variables and Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Impact Analysis
      • 3.2.1.1. Rise in government funding to reduce the maternal mortality
      • 3.2.1.2. Increasing incidence of post-partum depression
      • 3.2.1.3. Rise in awareness programs and efforts to improve practices around maternal mental healthcare
    • 3.2.2. Market Restraint Impact Analysis
      • 3.2.2.1. Mental health workforce shortage
      • 3.2.2.2. Social stigma surrounding postpartum depression
  • 3.3. Impact of the COVID-19 Pandemic
  • 3.4. Industry Analysis Tools
    • 3.4.1. Porter's Analysis
    • 3.4.2. Swot Analysis; By Factor (Political & Legal, Economic And Technological)

Chapter 4. North America Maternal Mental Health Market: Disease Indication Estimates & Trend Analysis

  • 4.1. Disease Indication Movement Analysis & Market Share, 2022 & 2030
  • 4.2. North America Maternal Mental Health Market Estimates & Forecast, By Disease Indication (USD Million)
  • 4.3. Postpartum Depression
    • 4.3.1. Global Postpartum Depression Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Dysthymia
    • 4.4.1. Global Dysthymia Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Pregnancy and Postpartum General Anxiety
    • 4.5.1. Global Pregnancy And Postpartum General Anxiety Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Pregnancy and Postpartum OCD
    • 4.6.1. Global Pregnancy And Postpartum OCD Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Birth-Related PTSD
    • 4.7.1. Global Birth-Related PTSD Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Global Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5. North America Maternal Mental Health Market: Therapy Estimates & Trend Analysis

  • 5.1. Therapy Movement Analysis & Market Share, 2022 & 2030
  • 5.2. North America Maternal Mental Health Market Estimates & Forecast, By Therapy (USD Million)
  • 5.3. Antidepressants
    • 5.3.1. Global Antidepressants Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Selective Serotonin Reuptake Inhibitors (SSRIs)
      • 5.3.2.1. Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Tricyclic Antidepressants (TCAs)
      • 5.3.3.1. Global Tricyclic Antidepressants (TCAs) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Others
      • 5.3.4.1. Global Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Interpersonal Psychotherapy (IPT)
    • 5.4.1. Global Interpersonal Psychotherapy (IPT) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Cognitive Behavioral Therapy (CBT)
    • 5.5.1. Global Cognitive Behavioral Therapy (CBT) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6. North America Maternal Mental Health Market: Regional Estimates and Trend Analysis

  • 6.1. North America Maternal Mental Health Market: Regional Outlook
  • 6.2. North America
    • 6.2.1. North America Maternal Mental Health Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Competitive Scenario
      • 6.2.2.3. Regulatory Framework
      • 6.2.2.4. U.S. North America Maternal Mental Health Market Estimates and Forecasts, 2018 - 2030 (USD MILLION)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Competitive Scenario
      • 6.2.3.3. Regulatory Framework
      • 6.2.3.4. Canada North America Maternal Mental Health Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. North America Maternal Mental Health Market: Competitive Landscape

  • 7.1. Participant Categorization
    • 7.1.1. Therapy Mama
      • 7.1.1.1. Overview
      • 7.1.1.2. Product Benchmarking
      • 7.1.1.3. Strategic Initiatives
    • 7.1.2. Canopie
      • 7.1.2.1. Overview
      • 7.1.2.2. Product Benchmarking
      • 7.1.2.3. Strategic Initiatives
    • 7.1.3. Pfizer Inc
      • 7.1.3.1. Overview
      • 7.1.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.1.3.3. Product Benchmarking
      • 7.1.3.4. Strategic Initiatives
    • 7.1.4. Viatris Inc.
      • 7.1.4.1. Overview
      • 7.1.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.1.4.3. Product Benchmarking
      • 7.1.4.4. Strategic Initiatives
    • 7.1.5. GlaxoSmithKline Inc.
      • 7.1.5.1. Overview
      • 7.1.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.1.5.3. Product Benchmarking
      • 7.1.5.4. Strategic Initiatives
    • 7.1.6. Alembic Pharmaceuticals Limited
      • 7.1.6.1. Overview
      • 7.1.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.1.6.3. Product Benchmarking
      • 7.1.6.4. Strategic Initiatives
    • 7.1.7. Mallinckrodt Inc.
      • 7.1.7.1. Overview
      • 7.1.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.1.7.3. Product Benchmarking
      • 7.1.7.4. Strategic Initiatives
    • 7.1.8. Sage Therapeutics, Inc.
      • 7.1.8.1. Overview
      • 7.1.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.1.8.3. Product Benchmarking
      • 7.1.8.4. Strategic Initiatives
    • 7.1.9. Bausch Health Companies Inc.
      • 7.1.9.1. Overview
      • 7.1.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.1.9.3. Product Benchmarking
      • 7.1.9.4. Strategic Initiatives
    • 7.1.10. Magellan Health, Inc.
      • 7.1.10.1. Overview
      • 7.1.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.1.10.3. Product Benchmarking
      • 7.1.10.4. Strategic Initiatives
  • 7.2. Participant's Overview
  • 7.3. Financial Performance
  • 7.4. Product Benchmarking
  • 7.5. Company Market Share Analysis, 2022
  • 7.6. Strategy Mapping
    • 7.6.1. Expansion
    • 7.6.2. Acquisition
    • 7.6.3. Product/Service Launch
    • 7.6.4. Others

Chapter 8. Analyst View

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviations
  • Table 3 North America maternal mental health market, by region, 2018 - 2030 (USD Million)
  • Table 4 North America maternal mental health market, by disease indication, 2018 - 2030 (USD Million)
  • Table 5 North America maternal mental health market, by therapy, 2018 - 2030 (USD Million)
  • Table 6 North America maternal mental health market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America maternal mental health market, by disease indication, 2018 - 2030 (USD Million)
  • Table 8 North America maternal mental health market, by therapy, 2018 - 2030 (USD Million)
  • Table 9 U.S. maternal mental health market, by disease indication, 2018 - 2030 (USD Million)
  • Table 10 U.S. maternal mental health market, by therapy, 2018 - 2030 (USD Million)
  • Table 11 Canada maternal mental health market, by disease indication, 2018 - 2030 (USD Million)
  • Table 12 Canada maternal mental health market, by therapy, 2018 - 2030 (USD Million)
  • Table 13 Company Overview
  • Table 14 Financial Performance
  • Table 15 Product Benchmarking
  • Table 16 Strategic Initiatives

List of Figures

  • Fig. 1 Maternal Mental Health market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation

Fig. 9 Market Outlook (2022)

  • Fig. 10 Segment Outlook
  • Fig. 11 Strategy framework
  • Fig. 12 Market driver relevance analysis (current & future impact)
  • Fig. 13 Market restraint relevance analysis (current & future impact)
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 16 North America maternal mental health market: disease indication movement analysis
  • Fig. 17 North America maternal mental health market, for postpartum depression, 2018 - 2030 (USD million)
  • Fig. 18 North America maternal mental health market, for dysthymia, 2018 - 2030 (USD million)
  • Fig. 19 North America maternal mental health market, for pregnancy and postpartum general anxiety, 2018 - 2030 (USD million)
  • Fig. 20 North America maternal mental health market, for pregnancy and postpartum OCD, 2018 - 2030 (USD million)
  • Fig. 21 North America maternal mental health market, for birth-related PTSD, 2018 - 2030 (USD million)
  • Fig. 22 North America maternal mental health market, for others, 2018 - 2030 (USD million)
  • Fig. 23 North America maternal mental health market: therapy movement analysis
  • Fig. 24 North America maternal mental health market, for antidepressants, 2018 - 2030 (USD million)
  • Fig. 25 North America maternal mental health market, for selective serotonin reuptake inhibitors, 2018 - 2030 (USD million)
  • Fig. 26 North America maternal mental health market, for tricyclic antidepressants, 2018 - 2030 (USD million)
  • Fig. 27 North America maternal mental health market, for others, 2018 - 2030 (USD million)
  • Fig. 28 North America maternal mental health market, for interpersonal psychotherapy, 2018 - 2030 (USD million)
  • Fig. 29 North America maternal mental health market, for cognitive behavioral therapy, 2018 - 2030 (USD million)
  • Fig. 30 North America maternal mental health market, for others, 2018 - 2030 (USD million)
  • Fig. 31 Regional marketplace: key takeaways
  • Fig. 32 Regional outlook, 2022 & 2030
  • Fig. 33 North America maternal mental health market: region movement analysis
  • Fig. 34 North America maternal mental health market, 2018 - 2030 (USD million)
  • Fig. 35 U.S. Maternal mental health market, 2018 - 2030 (USD million)
  • Fig. 36 Canada maternal mental health market, 2018 - 2030 (USD million)